AI assistant
FATE THERAPEUTICS INC — Director's Dealing 2013
Oct 7, 2013
34091_dirs_2013-10-07_d0170363-b807-4237-aad0-d862805e1cb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2013-10-04
Reporting Person: OVP VENTURE PARTNERS VII LP (10% Owner)
Reporting Person: OVP VII ENTREPRENEURS FUND LP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-04 | Common Stock | C | 669955 | — | Acquired | 669955 | Direct |
| 2013-10-04 | Common Stock | C | 702387 | — | Acquired | 1372342 | Direct |
| 2013-10-04 | Common Stock | C | 4723 | — | Acquired | 1377065 | Indirect |
| 2013-10-04 | Common Stock | C | 4951 | — | Acquired | 1382016 | Indirect |
| 2013-10-04 | Common Stock | J | 116629 | $6 | Acquired | 1498645 | Direct |
| 2013-10-04 | Common Stock | J | 822 | $6 | Acquired | 1499467 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-10-04 | Series A Convertible Preferred Stock | $ | C | 174982 | Disposed | Common Stock (174982) | Direct | |
| 2013-10-04 | Series A Convertible Preferred Stock | $ | C | 1234 | Disposed | Common Stock (1234) | Indirect | |
| 2013-10-04 | Series B Convertible Preferred Stock | $ | C | 611077 | Disposed | Common Stock (702387) | Direct | |
| 2013-10-04 | Series B Convertible Preferred Stock | $ | C | 4308 | Disposed | Common Stock (4951) | Indirect | |
| 2013-10-04 | Series C Convertible Preferred Stock | $ | C | 494973 | Disposed | Common Stock (494973) | Direct | |
| 2013-10-04 | Series C Convertible Preferred Stock | $ | C | 3489 | Disposed | Common Stock (3489) | Indirect |
Footnotes
F1: The aggregate number of shares of Issuer's Preferred Stock held by the Reporting Persons converted into Common Stock immediately prior to the closing of the Issuer's initial public offering and has no expiration date. These shares converted into Common Stock on a 1-for-1 basis.
F2: The aggregate number of shares of Issuer's Preferred Stock held by the Reporting Persons converted into Common Stock immediately prior to the closing of the Issuer's initial public offering and has no expiration date. These shares converted into Common Stock on approximately a 1-for-1.15 basis.
F3: These shares are owned directly by OVP Partners VII, L.P., whose sole general partner is OVMC VII, LLC ("OVMC"). The Reporting Person and OVMC each disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.
F4: These shares are owned directly by OVP VII Entrepreneurs Fund, L.P., whose sole general partner is OVMC. The Reporting Person and OVMC each disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.
F5: The shares were acquired upon conversion of a convertible promissory note exempt from the definition of a derivative security because the conversion price did not become fixed until automatic conversion at the time of the closing of the Issuer's initial public offering.